Physician profile
Aaron Weber
NPI 1497073027
$5,230.76
in general payments reported to CMS, 2019-2025
25 companies · $1,322 in 2025
The $1,322 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $134 · 2021: $421 · 2022: $1,258 · 2023: $425 · 2024: $1,241 · 2025: $1,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,987.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,758.26 | 2019-2025 | Clareon Panoptix Pro, Wavelight Refractive Suite, Argos |
| Bausch & Lomb Americas INC. | $602.36 | 2022-2025 | Miebo, Xiidra, Prolensa |
| Tarsus Pharmaceuticals, INC. | $558.66 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $304.42 | 2023-2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $257.06 | 2019-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $243.90 | 2019-2021 | |
| Dompe US, INC. | $224.12 | 2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $158.74 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $149.38 | 2019-2024 | Tecnis Iol, Tecnis Simplicity |
| Carl Zeiss Meditec USA, INC. | $144.69 | 2022 | |
| Allergan, INC. | $142.94 | 2022 | |
| Novartis Pharmaceuticals Corporation | $124.98 | 2019-2023 | |
| Apellis Pharmaceuticals, INC. | $110.73 | 2024 | Syfovre |
| Harrow Eye, LLC | $92.97 | 2024-2025 | Vevye, Iheezo, Ilevro |
| Abbvie INC. | $90.00 | 2022-2023 | Lumigan |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $76.18 | 2023-2025 | Omidria, Rayone Spheric, Rayone Emv |
| Sight Sciences, INC. | $30.33 | 2024 | Omni Surgical System |
| Rxsight INC | $30.00 | 2023 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Astellas Pharma US INC | $27.52 | 2024 | Izervay |
| Glaukos Corporation | $26.66 | 2025 | Istent Infinite |
| Oyster Point Pharma, INC. | $19.63 | 2025 | Tyrvaya, Ryzumvi |
| Shire North American Group INC | $18.50 | 2019 | |
| Ivantis, INC | $14.24 | 2021 | |
| Eyevance Pharmaceuticals LLC | $12.55 | 2019 | |
| Omeros Corporation | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.